[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire

FRANKLIN LAKES, N.J. , Aug. 17, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Gary Sorsher has been named...

BDX : 187.17 (+3.54%)
Are Wall Street Analysts Predicting Becton, Dickinson and Company Stock Will Climb or Sink?

Becton, Dickinson and Company has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

C : 132.70 (-3.60%)
$SPX : 7,716.23 (+0.32%)
BDX : 187.17 (+3.54%)
IHI : 56.64 (+2.16%)
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery

BDX : 187.17 (+3.54%)
Becton Dickinson: Fiscal Q3 Earnings Snapshot

Becton Dickinson: Fiscal Q3 Earnings Snapshot

BDX : 187.17 (+3.54%)
BD Reports Third Quarter Fiscal 2026 Financial Results

FRANKLIN LAKES, N.J. , Aug. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 third...

BDX : 187.17 (+3.54%)
BD's Three Consecutive Quarters of Losses Suggest the Turnaround Timeline Has Shifted

Barchart Research What to Expect from BDX Earnings BDX Generated August 5, 2026 Current Price $170.66 EPS Estimate $$3.14 Consensus Rating Moderate Buy Average Move 5.41% BD's Three Consecutive Quarters...

BDX : 187.17 (+3.54%)
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

  Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients.

BDX : 187.17 (+3.54%)
BD Board Declares Dividend

FRANKLIN LAKES, N.J. , July 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has...

BDX : 187.17 (+3.54%)
Mike Garrison to Retire from BD

FRANKLIN LAKES, N.J. , July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison...

BDX : 187.17 (+3.54%)
Becton, Dickinson and Company Earnings Preview: What to Expect

Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a double-digit profit dip.

XLV : 175.85 (+3.61%)
$SPX : 7,716.23 (+0.32%)
BDX : 187.17 (+3.54%)
WAT : 415.94 (+3.66%)

Barchart Exclusives

Dear Marvell Technology Stock Fans, Mark Your Calendars for August 27
Marvell Technology prepares for its Q2 results with analysts expecting huge upside. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.